These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 31489798)

  • 1. Regulation of bile acid metabolism-related signaling pathways by gut microbiota in diseases.
    Jia ET; Liu ZY; Pan M; Lu JF; Ge QY
    J Zhejiang Univ Sci B; 2019 Oct.; 20(10):781-792. PubMed ID: 31489798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bile Acid-Activated Receptors, Intestinal Microbiota, and the Treatment of Metabolic Disorders.
    Fiorucci S; Distrutti E
    Trends Mol Med; 2015 Nov; 21(11):702-714. PubMed ID: 26481828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism.
    Pathak P; Xie C; Nichols RG; Ferrell JM; Boehme S; Krausz KW; Patterson AD; Gonzalez FJ; Chiang JYL
    Hepatology; 2018 Oct; 68(4):1574-1588. PubMed ID: 29486523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of the Gut Microbiota in Bile Acid Metabolism.
    Ramírez-Pérez O; Cruz-Ramón V; Chinchilla-López P; Méndez-Sánchez N
    Ann Hepatol; 2017 Nov; 16(Suppl. 1: s3-105.):s15-s20. PubMed ID: 29080339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between gut bacteria and bile in health and disease.
    Long SL; Gahan CGM; Joyce SA
    Mol Aspects Med; 2017 Aug; 56():54-65. PubMed ID: 28602676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease.
    Chávez-Talavera O; Tailleux A; Lefebvre P; Staels B
    Gastroenterology; 2017 May; 152(7):1679-1694.e3. PubMed ID: 28214524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of gut microbiota with dysregulation of bile acids in the pathogenesis of nonalcoholic fatty liver disease and potential therapeutic implications of probiotics.
    Chen J; Thomsen M; Vitetta L
    J Cell Biochem; 2019 Mar; 120(3):2713-2720. PubMed ID: 30443932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crosstalk between Bile Acids and Gut Microbiota and Its Impact on Farnesoid X Receptor Signalling.
    Wahlström A; Kovatcheva-Datchary P; Ståhlman M; Bäckhed F; Marschall HU
    Dig Dis; 2017; 35(3):246-250. PubMed ID: 28249261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bile Acid Modifications at the Microbe-Host Interface: Potential for Nutraceutical and Pharmaceutical Interventions in Host Health.
    Joyce SA; Gahan CG
    Annu Rev Food Sci Technol; 2016; 7():313-33. PubMed ID: 26772409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between bile salts, gut microbiota, and hepatic innate immunity.
    Schubert K; Olde Damink SWM; von Bergen M; Schaap FG
    Immunol Rev; 2017 Sep; 279(1):23-35. PubMed ID: 28856736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crosstalk between bile acid-activated receptors and microbiome in entero-hepatic inflammation.
    Thibaut MM; Bindels LB
    Trends Mol Med; 2022 Mar; 28(3):223-236. PubMed ID: 35074252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiota, cirrhosis, and alcohol regulate bile acid metabolism in the gut.
    Ridlon JM; Kang DJ; Hylemon PB; Bajaj JS
    Dig Dis; 2015; 33(3):338-45. PubMed ID: 26045267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bile Acids and GPBAR-1: Dynamic Interaction Involving Genes, Environment and Gut Microbiome.
    Portincasa P; Di Ciaula A; Garruti G; Vacca M; De Angelis M; Wang DQ
    Nutrients; 2020 Nov; 12(12):. PubMed ID: 33266235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease-Associated Changes in Bile Acid Profiles and Links to Altered Gut Microbiota.
    Joyce SA; Gahan CG
    Dig Dis; 2017; 35(3):169-177. PubMed ID: 28249284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism.
    Wahlström A; Sayin SI; Marschall HU; Bäckhed F
    Cell Metab; 2016 Jul; 24(1):41-50. PubMed ID: 27320064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The gut microbiota at the intersection of bile acids and intestinal carcinogenesis: An old story, yet mesmerizing.
    Liu T; Song X; Khan S; Li Y; Guo Z; Li C; Wang S; Dong W; Liu W; Wang B; Cao H
    Int J Cancer; 2020 Apr; 146(7):1780-1790. PubMed ID: 31291465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bile acids as metabolic regulators.
    Li T; Chiang JY
    Curr Opin Gastroenterol; 2015 Mar; 31(2):159-65. PubMed ID: 25584736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway.
    Sun R; Yang N; Kong B; Cao B; Feng D; Yu X; Ge C; Huang J; Shen J; Wang P; Feng S; Fei F; Guo J; He J; Aa N; Chen Q; Pan Y; Schumacher JD; Yang CS; Guo GL; Aa J; Wang G
    Mol Pharmacol; 2017 Feb; 91(2):110-122. PubMed ID: 27932556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bile acid signaling in renal water regulation.
    Li S; Li C; Wang W
    Am J Physiol Renal Physiol; 2019 Jul; 317(1):F73-F76. PubMed ID: 31091123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FXR-Dependent Modulation of the Human Small Intestinal Microbiome by the Bile Acid Derivative Obeticholic Acid.
    Friedman ES; Li Y; Shen TD; Jiang J; Chau L; Adorini L; Babakhani F; Edwards J; Shapiro D; Zhao C; Carr RM; Bittinger K; Li H; Wu GD
    Gastroenterology; 2018 Dec; 155(6):1741-1752.e5. PubMed ID: 30144429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.